• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,363
2,300
1,861
1,850
1,725

COUNTRY

868
650
270
253
211

CATEGORIES

  • 858
  • 186
  • 679
  • 1,126
  • 391
  • 270
  • 253
  • 65
  • 378
  • 693
  • 1,330
  • 1,355
  • 625
  • 884
  • 1,695
  • 2,677
  • 507
  • 732
  • 0
  • 93

PRICE

7,150
12,250
18,493
25,172

PUBLISHED

1,689
2,624
7,173
25,172

PRODUCT TYPE

21,049
2,901
871
164
75
44
21
21
19
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Renal Insufficiency - Pipeline Review, H2 2013

Renal Insufficiency - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Renal Insufficiency - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM

Spinal Cord Injury - Pipeline Review, H2 2013

Spinal Cord Injury - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Spinal Cord Injury - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM

Astrocytoma - Pipeline Review, H2 2013

Astrocytoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Astrocytoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Adenocarcinoma - Pipeline Review, H2 2013

Adenocarcinoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Adenocarcinoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2013

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2013', provides an overview of the indication’s...

July 2013
FROM

United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2013

BMI View: The UAE's pharmaceuticals and healthcare market continues to grow, with the country standing out as a regional leader in areas such as medical tourism and its ability to attract multinational...

July 2013

Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth

Currently there are a number of disease-modifying drugs in the Multiple Sclerosis (MS) market that are indicated for the treatment of relapsing forms of the disease, specifically reducing the frequency...

July 2013
FROM

Seasonal Influenza - Pipeline Review, H2 2013

Seasonal Influenza - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Seasonal Influenza - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM

Ewing Sarcoma - Pipeline Review, H2 2013

Ewing Sarcoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ewing Sarcoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2013

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2013', provides an overview of the indication’s...

July 2013
FROM

Parkinson's Disease - Pipeline Review, H2 2013

Parkinson's Disease - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Parkinson's Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM

Bone Disorders - Pipeline Review, H2 2013

Bone Disorders - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Bone Disorders - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Lung Infections - Pipeline Review, H2 2013

Lung Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Lung Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

July 2013
FROM

Fallopian Tube Cancer - Pipeline Review, H2 2013

Fallopian Tube Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Fallopian Tube Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

July 2013
FROM

Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2013

Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

July 2013
FROM

T-Cell Leukemia - Pipeline Review, H2 2013

T-Cell Leukemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'T-Cell Leukemia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

July 2013
FROM

Kidney Fibrosis - Pipeline Review, H2 2013

'Kidney Fibrosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Kidney Fibrosis, complete...

July 2013
FROM

Nasopharyngeal Cancer - Pipeline Review, H2 2013

Nasopharyngeal Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Nasopharyngeal Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

July 2013
FROM

Liver Transplantation - Pipeline Review, H2 2013

Liver Transplantation - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Liver Transplantation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

July 2013
FROM

Neuroblastoma - Pipeline Review, H2 2013

Neuroblastoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Neuroblastoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM
Loading Indicator

Our Clients

Our clients' logos